News
Thrombotech reports positive stroke drug results
7 September 2010
Clal Biotechnology Industries Ltd. (TASE: CBI) portfolio company Thrombotech Technologies Ltd. reports positive results in the Phase I clinical trial of ...
Click on the link to read the full article at Globes (This link will open in a new window)Pharma news : Genus, GlaxoSmithKline, Genzyme, Dechra Pharmaceuticals
7 September 2010
Genus PLC GNS, who develop animal breeding biotechnology systems in non-genetically modified organism technology, have reported that profit before tax rose ...
Click on the link to read the full article at ukcitymedia (This link will open in a new window)Profits grow at Dechra Pharmaceuticals
7 September 2010
LONDON (SHARECAST) - Veterinary products group Dechra Pharmaceuticals posted a 10% rise in annual profit and hiked its dividend 18% as demand for its ...
Click on the link to read the full article at ShareCast (This link will open in a new window)Genentech example raises flags for Genzyme
7 September 2010
Genentech and Genzyme, based on opposite sides of the country, were long seen as leading US biotechnology pioneers. Genentech has 13000 employees, ...
Click on the link to read the full article at Boston Globe (This link will open in a new window)Mascoma Buys SunOpta BioProcess
7 September 2010
We believe that Mascoma is the ideal partner for SBI given its leading edge biotechnology in the conversion of non-food biomass into biofuels," said Steve ...
Click on the link to read the full article at Trading Markets (press release) (This link will open in a new window)DSM Launches InnoSyn? Route Scouting Services to Meet Pharmaceutical Company ...
7 September 2010
7 /PRNewswire/ -- DSM Pharma Chemicals, a business unit of DSM Pharmaceutical Products, today announced the launch of InnoSyn? route scouting services. ...
Click on the link to read the full article at PR Newswire (press release) (This link will open in a new window)Questor share tips: GSK a buy despite drug fears
7 September 2010
The UK's largest pharmaceutical company missed out on the stock market rally yesterday as its diabetes drug Avandia came under renewed scrutiny. ...
Click on the link to read the full article at Telegraph.co.uk (This link will open in a new window)Taiko Pharmaceutical Gains Most Since Listing on Drug-Resistant Bacteria
7 September 2010
Taiko Pharmaceutical Co., a Japanese maker of antiseptics, rose the most since listing on the Tokyo Stock ...
Click on the link to read the full article at Bloomberg (This link will open in a new window)Morocco Braces for a Shift to Generic Drugs
7 September 2010
Market Trends: More than 70% of the medicines sold in the Moroccan market are expected to swing into the generic space within the next three years. ...
Click on the link to read the full article at North Africa Journal (This link will open in a new window)Pharmaceutical firms must seek new frontiers
6 September 2010
With patents expiring in high numbers, new-product pipelines drying up and intensifying competition from generics, branded pharmaceuticals have been ...
Click on the link to read the full article at Gulf Times (This link will open in a new window)
- GlaxoSmithKline’s Avandia still available in UK, despite MHRA call for its suspension
- Israel relaxes restrictions on medical marijuana; scientists develop new HIV/AIDS treatment
- Tough road ahead for some generics after USA’s Federal Circuit Patent Use Code decisions
- Bausch & Lomb moves to acquire Miochol-E from Novartis as required by US competition authority
- German drug price curbs will hamper orphan drug development, says BIO Deutschland
